Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yoshio Okada

Showing results (91-100 of 101) with videos related to

Pageof 11
Sort By:
Bioorganic & Medicinal Chemistry Letters|September 27, 2005
New series of potent delta-opioid antagonists containing the H-Dmt-Tic-NH-hexyl-NH-R motifTingyou Li, Kimitaka Shiotani, Anna Miyazaki, et al.
Blood|March 23, 2017
Pharmacological targeting of plasmin prevents lethality in a murine model of macrophage activation syndromeHiroshi Shimazu, Shinya Munakata, Yoshihiko Tashiro, et al.
Pharmacology, Biochemistry, and Behavior|June 20, 2006
Potent in vivo antinociception and opioid receptor preference of the novel analogue [Dmt1]endomorphin-1Yunden Jinsmaa, Ewa Marczak, Yoshio Fujita, et al.
Bioorganic & Medicinal Chemistry Letters|January 25, 2005
Studies on the structure-activity relationship of 2',6'-dimethyl-l-tyrosine (Dmt) derivatives: bioactivity profile of H-Dmt-NH-CH(3)Yoshio Fujita, Yuko Tsuda, Takashi Motoyama, et al.
Journal of Medicinal Chemistry|April 30, 2004
Oral bioavailability of a new class of micro-opioid receptor agonists containing 3,6-bis[Dmt-NH(CH(2))(n)]-2(1H)-pyrazinone with central-mediated analgesiaYunden Jinsmaa, Anna Miyazaki, Yoshio Fujita, et al.
Journal of Medicinal Chemistry|December 13, 2005
Potent Dmt-Tic pharmacophoric delta- and mu-opioid receptor antagonistsTingyou Li, Yoshio Fujita, Kimitaka Shiotani, et al.
Bioorganic & Medicinal Chemistry|December 5, 2006
Transformation of mu-opioid receptor agonists into biologically potent mu-opioid receptor antagonistsTingyou Li, Yunden Jinsmaa, Masahiro Nedachi, et al.
Journal of Medicinal Chemistry|June 25, 2004
Development of potent bifunctional endomorphin-2 analogues with mixed mu-/delta-opioid agonist and delta-opioid antagonist propertiesYoshio Fujita, Yuko Tsuda, Tingyou Li, et al.
Gastroenterology|December 10, 2014
Inhibition of plasmin protects against colitis in mice by suppressing matrix metalloproteinase 9-mediated cytokine release from myeloid cellsShinya Munakata, Yoshihiko Tashiro, Chiemi Nishida, et al.
Blood|February 8, 2011
Murine prolylcarboxypeptidase depletion induces vascular dysfunction with hypertension and faster arterial thrombosisGregory N Adams, Gretchen A LaRusch, Evi Stavrou, et al.
Pageof 11

Showing results (91-100 of 101) with videos related to

Sort By:
Pageof 11
Bioorganic & Medicinal Chemistry Letters|September 27, 2005
New series of potent delta-opioid antagonists containing the H-Dmt-Tic-NH-hexyl-NH-R motifTingyou Li, Kimitaka Shiotani, Anna Miyazaki, et al.
Blood|March 23, 2017
Pharmacological targeting of plasmin prevents lethality in a murine model of macrophage activation syndromeHiroshi Shimazu, Shinya Munakata, Yoshihiko Tashiro, et al.
Pharmacology, Biochemistry, and Behavior|June 20, 2006
Potent in vivo antinociception and opioid receptor preference of the novel analogue [Dmt1]endomorphin-1Yunden Jinsmaa, Ewa Marczak, Yoshio Fujita, et al.
Bioorganic & Medicinal Chemistry Letters|January 25, 2005
Studies on the structure-activity relationship of 2',6'-dimethyl-l-tyrosine (Dmt) derivatives: bioactivity profile of H-Dmt-NH-CH(3)Yoshio Fujita, Yuko Tsuda, Takashi Motoyama, et al.
Journal of Medicinal Chemistry|April 30, 2004
Oral bioavailability of a new class of micro-opioid receptor agonists containing 3,6-bis[Dmt-NH(CH(2))(n)]-2(1H)-pyrazinone with central-mediated analgesiaYunden Jinsmaa, Anna Miyazaki, Yoshio Fujita, et al.
Journal of Medicinal Chemistry|December 13, 2005
Potent Dmt-Tic pharmacophoric delta- and mu-opioid receptor antagonistsTingyou Li, Yoshio Fujita, Kimitaka Shiotani, et al.
Bioorganic & Medicinal Chemistry|December 5, 2006
Transformation of mu-opioid receptor agonists into biologically potent mu-opioid receptor antagonistsTingyou Li, Yunden Jinsmaa, Masahiro Nedachi, et al.
Journal of Medicinal Chemistry|June 25, 2004
Development of potent bifunctional endomorphin-2 analogues with mixed mu-/delta-opioid agonist and delta-opioid antagonist propertiesYoshio Fujita, Yuko Tsuda, Tingyou Li, et al.
Gastroenterology|December 10, 2014
Inhibition of plasmin protects against colitis in mice by suppressing matrix metalloproteinase 9-mediated cytokine release from myeloid cellsShinya Munakata, Yoshihiko Tashiro, Chiemi Nishida, et al.
Blood|February 8, 2011
Murine prolylcarboxypeptidase depletion induces vascular dysfunction with hypertension and faster arterial thrombosisGregory N Adams, Gretchen A LaRusch, Evi Stavrou, et al.
Pageof 11